A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more
Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more
The European Union removed the U.S. from its safe travel list earlier this week, as the Biden administration took measures to bolster the vaccine supply chain to meet the anticipated rise in demand.
Children Account for...more
New initiatives and some promising developments in vaccine trials, contact tracing efforts, and the production of more efficient COVID-19 detection testing highlighted an active week in the scientific community’s response to...more